CytomX Therapeutics (CTMX) Competitor Comparison
We are evaluating the key criteria listed to compare CytomX Therapeutics (CTMX) against its competitors in the Biotechnology industry.
Market Capitalization
240 / 368Gross Profits
63 / 278Total Revenue
93 / 300EBITDA
40 / 337Free Cashflow
20 / 352Quick Ratio
316 / 357Earnings per Share
35 / 359Dividend yield
0 / 6Total Cash
159 / 358Performance 3 years
241 / 368Performance 5 years
255 / 368Performance 10 years
271 / 368Linearity 3 years
223 / 368Linearity 5 years
164 / 368Linearity 10 years
137 / 367Total Rank
104 / 368Dividend Rank
105 / 368Valuation Rank
124 / 368Piotroski Rank
352 / 368Muliplier Rank
30 / 368Free Cashflow - CTMX ranking 20 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.